Skip to main content
Erschienen in: Indian Journal of Gastroenterology 1/2017

17.12.2016 | Original Article

Predictors of severe outcomes in patients with Clostridium difficile infection from a Hispanic population

verfasst von: Laura Paláu-Dávila, Elvira Garza-González, Eva María Gutiérrez-Delgado, Adrián Camacho-Ortiz

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Factors associated with complicated Clostridium difficile infection (CDI) may vary among populations, and predictors of severe outcomes in CDI have not been studied in Hispanic patients. The aim of this study was to identify factors associated with a higher risk of colectomy, all-cause mortality, and CDI-associated mortality in a Hispanic population.

Methods

We performed a retrospective study of all hospitalized patients with a diagnosis of CDI between January 1, 2011 and September 30, 2015 in a 450-bed teaching hospital in Monterrey, northeast Mexico. Three main outcomes were defined: fulminant colitis with subsequent colectomy, all-cause mortality within 30 days of diagnosis, and CDI-attributable mortality.

Results

Of 261 patients with diarrhea, 176 were diagnosed with CDI. For colectomy, Charlson comorbidity index, ICU stay and mechanical ventilation prior to CDI diagnosis, days with diarrhea prior to treatment, total days of hospital stay and days after CDI diagnosis, elevated ATLAS score, days of diarrhea post CDI treatment, and treatment failure significantly predicted the necessity of surgical treatment with colectomy.

Conclusion

Treatment failure, persistent diarrhea, and a high ATLAS score were identified as risk factors for severe outcomes of CDI. A low albumin concentration and high creatinine were associated with higher overall mortality.
Literatur
1.
Zurück zum Zitat Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.CrossRefPubMed Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.CrossRefPubMed
2.
Zurück zum Zitat Postma N, Kiers D, Pickkers P. The challenge of Clostridium difficile infection: overview of clinical manifestations, diagnostic tools and therapeutic options. Int J Antimicrob Agents. 2015;46 Suppl 1:S47–50.CrossRefPubMed Postma N, Kiers D, Pickkers P. The challenge of Clostridium difficile infection: overview of clinical manifestations, diagnostic tools and therapeutic options. Int J Antimicrob Agents. 2015;46 Suppl 1:S47–50.CrossRefPubMed
3.
Zurück zum Zitat McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–41.CrossRefPubMed McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–41.CrossRefPubMed
4.
Zurück zum Zitat Abou Chakra CN, McGeer A, Labbé AC, et al. Factors associated with complications of Clostridium difficile infection in a multicenter prospective cohort. Clin Infect Dis. 2015;61:1781–8.CrossRefPubMedPubMedCentral Abou Chakra CN, McGeer A, Labbé AC, et al. Factors associated with complications of Clostridium difficile infection in a multicenter prospective cohort. Clin Infect Dis. 2015;61:1781–8.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Hensgens MP, Dekkers OM, Goorhuis A, LeCessie S, Kuijper EJ. Predicting a complicated course of Clostridium difficile infection at the bedside. Clin Microbiol Infect. 2014;20:O301–8.CrossRefPubMed Hensgens MP, Dekkers OM, Goorhuis A, LeCessie S, Kuijper EJ. Predicting a complicated course of Clostridium difficile infection at the bedside. Clin Microbiol Infect. 2014;20:O301–8.CrossRefPubMed
6.
Zurück zum Zitat Xu S, Huang H, Li G. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Chinese J Infect Chemother. 2011;11:426–7. Xu S, Huang H, Li G. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Chinese J Infect Chemother. 2011;11:426–7.
7.
Zurück zum Zitat Miller MA, Louie T, Mullane K. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection, which predicts response to therapy. BMC Infect Dis. 2013;13:148.CrossRefPubMedPubMedCentral Miller MA, Louie T, Mullane K. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection, which predicts response to therapy. BMC Infect Dis. 2013;13:148.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Na X, Martin AJ, Sethi S, et al. A multi-center prospective derivation and validation of a clinical prediction tool for severe Clostridium difficile infection. PLoS One. 2015;10:e0123405.CrossRefPubMedPubMedCentral Na X, Martin AJ, Sethi S, et al. A multi-center prospective derivation and validation of a clinical prediction tool for severe Clostridium difficile infection. PLoS One. 2015;10:e0123405.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Balassiano IT, Yates EA, Domingues RM, Ferreira EO. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. J Med Microbiol. 2012;61:169–79.CrossRefPubMed Balassiano IT, Yates EA, Domingues RM, Ferreira EO. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. J Med Microbiol. 2012;61:169–79.CrossRefPubMed
10.
Zurück zum Zitat Aguayo C, Flores R, Lévesque S, et al. Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America. Epidemiol Infect. 2015;143:3069–73.CrossRefPubMed Aguayo C, Flores R, Lévesque S, et al. Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America. Epidemiol Infect. 2015;143:3069–73.CrossRefPubMed
11.
Zurück zum Zitat López-Ureña D, Quesada-Gómez C, Miranda E, Fonseca M, Rodríguez-Cavallini E. Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama. J Med Microbiol. 2014;63:322–4.CrossRefPubMed López-Ureña D, Quesada-Gómez C, Miranda E, Fonseca M, Rodríguez-Cavallini E. Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama. J Med Microbiol. 2014;63:322–4.CrossRefPubMed
12.
Zurück zum Zitat Quesada-Gómez C, Mulvey MR, Vargas P, Gamboa-Coronado M del M, Rodríguez C, Rodríguez-Cavillini E. Isolation of a toxigenic and clinical genotype of Clostridium difficile in retail meats in Costa Rica. J Food Prot 2013;76: 348–51. Quesada-Gómez C, Mulvey MR, Vargas P, Gamboa-Coronado M del M, Rodríguez C, Rodríguez-Cavillini E. Isolation of a toxigenic and clinical genotype of Clostridium difficile in retail meats in Costa Rica. J Food Prot 2013;76: 348–51.
13.
Zurück zum Zitat Camacho-Ortiz A, López-Barrera D, Hernández-García R, et al. First report of Clostridium difficile NAP1/027 in a Mexican hospital. PLoS One. 2015;10:1–10. Camacho-Ortiz A, López-Barrera D, Hernández-García R, et al. First report of Clostridium difficile NAP1/027 in a Mexican hospital. PLoS One. 2015;10:1–10.
14.
Zurück zum Zitat Kim SC, Seo MY, Lee JY, et al. Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection. Korean J Intern Med. 2016;31:125–33.CrossRefPubMed Kim SC, Seo MY, Lee JY, et al. Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection. Korean J Intern Med. 2016;31:125–33.CrossRefPubMed
15.
Zurück zum Zitat Thongprayoon C, Cheungpasitporn W, Phatharacharukul P, et al. Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis. Int J Clin Pract. 2015;69:998–1006.CrossRefPubMedPubMedCentral Thongprayoon C, Cheungpasitporn W, Phatharacharukul P, et al. Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis. Int J Clin Pract. 2015;69:998–1006.CrossRefPubMedPubMedCentral
Metadaten
Titel
Predictors of severe outcomes in patients with Clostridium difficile infection from a Hispanic population
verfasst von
Laura Paláu-Dávila
Elvira Garza-González
Eva María Gutiérrez-Delgado
Adrián Camacho-Ortiz
Publikationsdatum
17.12.2016
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 1/2017
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-016-0722-4

Weitere Artikel der Ausgabe 1/2017

Indian Journal of Gastroenterology 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.